Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factor release via paracrine stimulation is a cell-to-cell communication mechanism where cells secrete growth factors that act on nearby cells to regulate their behavior, proliferation, differentiation, and survival. This process is crucial in tissue repair, angiogenesis, and modulating inflammation. Key growth factors involved include FGFs, VEGF, EGF, and PDGF, which activate intracellular signaling pathways like MAPK/ERK, PI3K/Akt, and JAK/STAT, leading to changes in gene expression. Paracrine effects are central to stem cell therapies, promoting endogenous repair mechanisms in host tissues. The effects depend on the type and amount of released factors, receptor presence on target cells, and local microenvironmental cues.
Paracrine stimulation involves the release of growth factors from cells, which then bind to receptors on nearby cells, triggering intracellular signaling cascades (e.g., MAPK/ERK, PI3K/Akt, JAK/STAT) that alter gene expression and cellular behavior.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Factor Release (Paracrine Stimulation).